“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Cell of origin in diffuse large B-cell lymphoma: the way to targeted therapy?

€3.03

SKU: product-article-14720 Category: General

Description
Reviews (0)

Description

Cell of origin in diffuse large B-cell lymphoma: the way to targeted therapy?

Reviews

There are no reviews yet.

Be the first to review “Article: Cell of origin in diffuse large B-cell lymphoma: the way to targeted therapy?”

You must be logged in to post a review.

Top

Article: Cell of origin in diffuse large B-cell lymphoma: the way to targeted therapy?

Description

Reviews

Related products

Article: Calendar of events

Article: Highlights in melanoma

Article: Highlights in urologic cancer

Article: Highlights in breast cancer